Formulation optimization of nifedipine containing microspheres using factorial design

African Journal of Pharmacy and Pharmacology

Volumn 4, Issue 6, 2010, Pages 346-354

  Dehghan, Solmaz ^a,b   Aboofazeli, Reza ^a   Avadi, Mohammadreza ^a   Khaksar, Ramin ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Eudragit RL100; Factorial design; Microsphere; Nifedipine; Solvent evaporation

Indexed keywords

EUDRAGIT; MICROSPHERE; NIFEDIPINE; POLYVINYL ALCOHOL;

ARTICLE; CONTROLLED STUDY; ENCAPSULATION; EVAPORATION; FACTORIAL DESIGN; PARTICLE SIZE; POLYMERIZATION; PROCESS OPTIMIZATION; RESPONSE SURFACE METHOD; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE FORMULATION;

EID: 77954667445     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bhavar MD, Tiwari SB, Amiji MM (2006). Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design, J. Control Rel. 110: 422-430.
2. Cohen S, Yoshiaka T, Lucarelli M (1991). Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm. Res. 8: 713-720.
3. Dinarvandr, Zainali B, Atyabi F (2001). Effects of formulation variables on nifedipine microspheres prepared by solvent evaporation technique. Daru 9: 33-40.
4. Freitas S, Merkle HP, Gander B (2005). Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J. Control. Rel. 102: 313-332.
5. Gibaud S, Bonneville A, Astier A (2002). Preparation of 3, 4-diaminopyridine microparticles by solvent-evaporation methods. Int. J. Pharm. 242: 197-201.
6. Kilicarslan M, Baykara T (2003). The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. Int. J. Pharm. 252: 99-109.
7. Malamataris S, Avgerino A (1990). Controlled release indomethacin microspheres prepared by using an emulsion solvent-diffusion technique. Int. J. Pharm. 62: 105-111.
8. Martinez-Sancho C, Herrero-Vanrell R, Negro S (2004). Optimisation of aciclovir poly (D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study. Int. J. Pharm. 273: 45-56.
9. Mateovic T, Kriznar B, Bogotaj M, Mrhar A (2002). The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. J. Microencapsulation 19: 29-36.
10. Okor RS (1990). Drug release on certain acrylate methacylate-salicylic acid coacervate systems, J. Control Rel. 12: 195-200.
11. Oth MP, Moes AJ (1989). Sustained release solid dispersions of indomethacin with Eudragit RS, RL. Int. J. Pharm. 55: 157-164.
12. Vasir JK, Tambwekar K, Garg S (2003). Bioadhesive microspheres as a controlled drug delivery system. Int. J. Pharm. 255: 13-32.
13. Yang M, Cui F, You B, Fan Y, Wang L, Yue P, Yang H (2003). Preparation of sustained-release nitrendipine microspheres with Eudragit RS and Aerosil using quasi-emulsion solvent diffusion method. Int. J. Pharm. 259: 103-113.
14. Yuksel N, Turkoglu M, Baykara T (2000). Modelling of the solvent evaporation method for the preparation of controlled release acrylic microspheres using neural networks. J. Microencapsul. 17: 541-551.
15. Usp (2000). USP, 24th edn (Rockville: United States Pharmacopeial Convention Inc) pp. 1941-1943.